52 studies found for:    Open Studies | "Organ Transplantation"
Show Display Options
Rank Status Study
21 Recruiting Imiquimod Versus Photodynamic Therapy of Actinic Keratoses in Organ Transplant Recipients
Condition: Actinic Keratoses
Interventions: Other: photodynamic therapy;   Drug: imiquimod 5% cream
22 Recruiting Phase III, Study to Evaluate the Efficacy of Two Different HBV Vaccination Schemes in Patients With Hepatic Cirrhosis
Conditions: Hepatitis B;   Cirrhosis;   Awaiting Organ Transplant
Intervention: Biological: HBV vaccine
23 Recruiting Bortezomib Plus Rituximab for EBV+ PTLD
Conditions: Post-transplant Lymphoproliferative Disease;   Solid Organ Transplant;   Stem Cell Transplant (Bone Marrow Transplant);   Epstein Barr Virus Infections
Interventions: Drug: bortezomib;   Drug: rituximab
24 Recruiting Prospective Clinical Evaluation of Beta-D-Glucan Assay in Blood and BAL
Conditions: Invasive Fungal Infection;   Hematological Malignancy;   Receipt of Solid Organ Transplant
Intervention: Other: Fungitell Assay in BAL
25 Unknown  Is Self-Reported Quality Assessment in Surgery Reliable?
Condition: Patients of Visceral- and Transplantation Surgery
Intervention: Procedure: Reliability of complication assessment
26 Recruiting "Efficacy and Safety of Levofloxacin vs Isoniazid in Latent Tuberculosis Infection in Liver Transplant Patients".
Conditions: Latent Tuberculosis Infection;   Infection in Solid Organ Transplant Recipients
Interventions: Drug: Levofloxacin;   Drug: Isoniazid
27 Recruiting Natural History of Cytomegalovirus (CMV) Infection and Disease Among Renal Transplant Recipients
Condition: Infection in Solid Organ Transplant Recipients
Intervention:
28 Recruiting Survey of Severe Infections by Gram Negative Bacteria in Patients Submitted to Stem Cell Transplant
Conditions: Complications of Organ Transplant Stem Cells;   Gram-Negative Bacterial Infections
Intervention:
29 Recruiting Individualization of Ganciclovir and Valganciclovir Doses Using Bayesian Prediction in Renal Transplant Patients.
Condition: Infection in Solid Organ Transplant Recipients
Interventions: Drug: Ganciclovir/ Valganciclovir according to SPC;   Drug: Ganciclovir/ Valganciclovir according to PK model
30 Recruiting Trial of Regulatory T-cells Plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic Graft-versus-Host-Disease
Conditions: Chronic Graft Versus Host Disease;   Chronic GVHD;   Complications of Organ Transplant Stem Cells
Interventions: Other: Treg-enriched infusion;   Drug: Interleukin-2
31 Not yet recruiting Aggressive Squamous Cell Carcinoma in Organ Transplant Recipients
Condition: Squamous Cell Carcinoma
Intervention:
32 Not yet recruiting Metastases of Cutaneous Squamous Cell Carcinoma in Organ Transplant Recipients. The "SCOPE-ITSCC Metastases Study"
Condition: Squamous Cell Carcinoma
Intervention: Other: SCC metastasis
33 Recruiting Glucose/Insulin Clamp on Solid Organ Transplant (Liver, Kidney, Pancreas and Heart) on Cadaveric Donors
Condition: Complication of Transplanted Organ, Nos
Intervention: Other: Hyperinsulinemic/normoglycemic clamp
34 Recruiting A Study to Determine Pharmacokinetics of Children Receiving Modigraf (Tacrolimus Granules) Following Solid Organ Transplantation
Conditions: Liver Transplantation;   Kidney Transplantation;   Heart Transplantation
Intervention: Drug: Tacrolimus granules
35 Recruiting Studies of Organ Transplantation in Animals and Man
Condition: Diabetes Mellitus
Intervention:
36 Recruiting Reference Group Trial for The ONE Study
Conditions: End-stage Renal Failure;   Kidney Graft Rejection
Intervention: Other: Blood drawing for immune monitoring and questionnaires
37 Recruiting EVER(Epidermodysplasia Verruciformis Levandowsky-Lutz)/TMC(TransMembral Channel Like Protein) Mutation as Marker of the Risk of Cutaneous Carcinoma in Immunosuppressed Patients
Conditions: Immunosuppression;   Neoplasm
Intervention:
38 Recruiting Cancer Risk in Organ Transplant Recipients and End-Stage Renal Disease
Condition: End-Stage Renal Disease
Intervention:
39 Recruiting Evaluate Reactogenicity and Immunogenicity of Standard-dose (SD) Versus High-dose (HD) Inactivated Influenza Vaccine Trivalent (IIV3) in Recipients of Solid Organ Transplants.
Conditions: Influenza, Human;   Transplantation Infection
Interventions: Biological: influenza trivalent inactive vaccine;   Biological: influenza trivalent inactive vaccine high dose
40 Recruiting A Study to Compare How the Body Absorbs and Processes Two Different Formulations of the Anti-rejection Medication Tacrolimus (Advagraf® or Prograf®) in Children Receiving an Organ Transplant, and How Safe and Effective They Are Over a Longer Period of Time
Conditions: Kidney Transplantation;   Liver Transplantation;   Heart Transplantation
Interventions: Drug: Prograf®;   Drug: Advagraf

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-52) Show next page of results
Indicates status has not been verified in more than two years